Remission in Nonradiographic Axial Spondyloarthritis Treated with Anti-tumor Necrosis Factor-α Drugs: An Italian Multicenter Study.

CONCLUSION: Our results, obtained from clinical practice, showed that PR is an achievable target of anti-TNF-α treatment in nr-axSpA. The PR rate, as a reliable indicator of sustained effectiveness, is similar in nr-axSpA and in AS. PMID: 25512483 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25512483?dopt=Abstract

Source: J Rheumatol - December 15, 2014 Category: Rheumatology Authors: Lubrano E, Perrotta FM, Marchesoni A, D'Angelo S, Ramonda R, Addimanda O, Olivieri I, Punzi L, Salvarani C Tags: J Rheumatol Source Type: research